Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_assertion type Assertion NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_head.
- NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_provenance.
- NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_assertion evidence source_evidence_literature NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_provenance.
- NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_assertion SIO_000772 20959405 NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_provenance.
- NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_assertion wasDerivedFrom gad-20150221 NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_provenance.
- NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_assertion wasGeneratedBy ECO_0000203 NP89458.RA45bMsSiXY3OITw8eIUJXCv5H1uoEeVnNROa5gRMkd_k130_provenance.